Larimar Therapeutics, Inc. — Director's Dealing 2021

May 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Larimar Therapeutics, Inc. (LRMR)
CIK: 0001374690
Period of Report: 2021-05-12

Reporting Person: Daniel Thomas O (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-12	Stock Option (right to buy)	$10.34	A	8300	Acquired	2031-05-12	Common Stock (8300)	Direct

Footnotes

F1: The Option vests on the earlier of (a) May 12, 2022 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.